Ellington Management Group’s Cantel Medical Corporation CMD Stock Holding History

Ellington Management Group’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,300	Closed	-$370K	–	505
2020 Q1	$370K	Buy	+10,300	New	+$586K	0.09%	286
2018 Q2	–	Sell	-3,700	Closed	-$412K	–	968
2018 Q1	$412K	Buy	+3,700	New	+$415K	0.03%	474
2017 Q1	–	Sell	-3,100	Closed	-$244K	–	931
2016 Q4	$244K	Buy	+3,100	New	+$241K	0.04%	381
2014 Q2	–	Sell	-9,300	Closed	-$314K	–	723
2014 Q1	$314K	Buy	+9,300	New	+$307K	0.09%	345

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ellington Management Group's CMD Position: Q2 2020 in Review

Ellington Management Group sold out of Cantel Medical Corporation (CMD) in Q2 2020, closing a stake of 10,300 shares — an estimated $370K sold.

Ellington Management Group first reported a position in CMD in Q1 2014 and held it in 4 quarters. The position peaked at $412K in Q1 2018. 210 funds tracked by Wall St. Rank hold CMD as of Q2 2020.

Ellington Management Group reported no remaining Cantel Medical Corporation position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 10,300 Cantel Medical Corporation shares in Q2 2020, an estimated $370K.
Ellington Management Group first reported a position in Cantel Medical Corporation in Q1 2014 and held it in 4 quarters.
Ellington Management Group's Cantel Medical Corporation position peaked at $412K in Q1 2018.
210 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.